August 24, 2022
RegMed Investors’ (RMi) pre-open: markets and sector will remain volatile
August 22, 2022
RegMed Investors’ (RMi) pre-open: the cell and gene therapy sucked pond water most of last week
August 19, 2022
RegMed Investors’ (RMi) pre-open: the cell and gene therapy sector begs for direction on option expiration Friday
August 18, 2022
RegMed Investors’ (RMi) pre-open: a mixed trend with a bit of a bounce-back
August 17, 2022
RegMed Investors’ (RMi) pre-open: volatility + weak LPS (loss-per-share) = declining conviction and confidence
August 16, 2022
RegMed Investors’ (RMi) pre-open: incoming, duck and squat
August 15, 2022
RegMed Investors’ (RMi) pre-open: chutes and ladders, Monday
August 12, 2022
RegMed Investors’ (RMi) pre-open: it’s a take your profits and run Friday
August 11, 2022
RegMed Investors’ (RMi) pre-open: show me the money; I’ll take cash, my powder has gotten dry
August 10, 2022
RegMed Investors’ (RMi) pre-open: the tug-of-war as Wednesday's inflation report could be a short-term catalyst
August 8, 2022
RegMed Investors’ (RMi) pre-open: as the upside party rages on, is sector share pricing support solid?
August 4, 2022
RegMed Investors’ (RMi) pre-open: post earnings, remember Isaac Newton’s apple, gravity caused a bonk on the head
August 3, 2022
RegMed Investors’ (RMi) pre-open: earnings and more earnings with a few shots-in -the dark
August 2, 2022
RegMed Investors’ (RMi) pre-open: earnings’ week expectation, can’t take them all to the bank
August 1, 2022
RegMed Investors’ (RMi) pre-open: will August be the month of my portfolio’s discontent?
July 29, 2022
RegMed Investors’ (RMi) pre-open: Finish the week and July with it
July 28, 2022
RegMed Investors’ (RMi) pre-open: Q2 GDP and sector earnings initiation
July 27, 2022
RegMed Investors’ (RMi) pre-open: the Fed speaks today at 2 p.m.
July 26, 2022
RegMed Investors’ (RMi) pre-open: a pivotal month ending week
July 25, 2022
RegMed Investors’ (RMi) pre-open: walking a tightrope of the oversold
July 22, 2022
RegMed Investors’ (RMi) pre-open: are risk parameters crashing the cell and gene therapy sector?
July 21, 2022
RegMed Investors’ (RMi) pre-open: the algos are coming, share pricing on a platter
5 hours 50 min ago
RegMed Investors’ (RMi) pre-open: Q4 kicks off
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2022 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.